Erlocip 150mg Tablets
Get Price Quote
10 Bottle (MOQ)
Erleva Erlotinib Tablets
Get Price Quote
Erleva Specifications :- Brand name : Erleva Content : Erlotinib 100mg & 150mg Form : Tablets Strength : 100mg & 150 mg Packing : 30 Tablets Manufactured by : Onkos Note :- Erleva is a prescription drug and should be used under proper medical guidance and advice. Do not share the medicine with others, since they may be suffering from a problem that is not effectively treated by this drug...
Best Deals from Erlotinib Tablets
Erlocip 150mg Tablets
4,499 Per Bottle
1 Bottle (MOQ)
Erlotinib 150 Mg Tablets
10,000 Per Bottle
20 Bottle (MOQ)
Erlocip 150 Tablet 30's belongs to the group of medicine called 'anti-cancer' primarily used for lung and pancreatic cancer treatment. Lung cancer is the uncontrolled growth of abnormal cells in one or both lungs
Erlonat 150mg Tablets
2,700 Per Bottle
1 Bottle (MOQ)
Zyceva 150mg Tablets
1,600 - 1,700 Per Bottle
10 Bottle (MOQ)
Erlotinib Tablets
Get Price Quote
A drug used alone to treat certain types of non-small cell lung cancer and with gemcitabine hydrochloride to treat certain types of pancreatic cancer. It is also being studied in the treatment of other types of cancer. Erlotinib hydrochloride blocks a protein called EGFR, which may help keep cancer cells from growing. It is a type of tyrosine kinase inhibitor. Also called CP-358,774, OSI-774, and Tarceva. US Brand Name(s): Tarceva. FDA Approved: Yes Erlotinib, sold under the brand name Tarceva among others, is a medication used to treat non-small cell lung cancer (NSCLC) and pancreatic cancer. Specifically it is used for NSCLC with mutations in the epidermal growth factor receptor (EGFR) — either an exon 19 deletion (del19) or exon 21 (L858R) substitution mutation — which has spread to other parts of the body. It is taken by mouth. Erlotinib was approved for medical use in the United States in 2004. It is on the World Health Organization’s List of Essential Medicines. Use in Cancer Erlotinib hydrochloride is approved to be used alone or with other drugs to treat: Non-small cell lung cancer (NSCLC) that is metastatic and has certain EGFR gene mutations. The use of erlotinib hydrochloride to treat NSCLC that does not have the EGFR gene mutations is no longer FDA-approved. Pancreatic cancer. It is used with gemcitabine hydrochloride in patients whose disease cannot be removed by surgery, is locally advanced, or has metastasized. Erlotinib hydrochloride is also being studied in the treatment of other types of cancer.
Erlotinib Tablets IP 150mg ( Erlonat)
7,500 Per Bottle
2 Bottle(s) (MOQ)
Erlotinib is used to treat lung and pancreatic cancer. It works by slowing or stopping the growth of cancer cells.
Erlotinib Tablet
Get Price Quote
We have earned an outstanding position in the market because of our flawless quality range of Erlotinib Tablet. Used for treating pancreatic cancer, our offered erlotinib tablet is formulated by vendor’s trained medical professionals under strict guidelines of quality standards. In order to satisfy our clients, the offered erlotinib tablet can be provided in safe packaging options. Moreover, our offered erlotinib tablet can be taken from us at fair price.
Erlotinib Tablets
2,500 Per Bottle
1 Bottle (MOQ)
Tablet is used in the treatment of non-small cell lung cancer and pancreatic cancer
Zyceva 150mg Tablets
1,600 - 1,700 Per Box
2 Bottle (MOQ)
Zyceva 150 mg Erlotinib Supplier in Mumbai Zyceva tablet Erlotinib Supplier in Mumbai Erlotinib 100 mg Supplier in Ahmedabad
Erlotinib 100mg Tablets
5,900 Per boxes
1000 boxes (MOQ)
Erlotinib Tablet
200 - 300 Per Box
Erlotinib Tablet is the most effective tablet that helps in treating advanced small lung cancer, and pancreatic cancer. The tablet is film-coated at a highly efficient rate. The therapist refers to this after a complete diagnosis. Moreover, our delivery team dispatched this medicine at the committed time. Its price is well managed by our marketing experts which is suitable for every customer.
Erlocip 150mg Tablets
6,000 Per Box
10 Box (MOQ)
ZYCEVA 100mg Tablets
Get Price Quote
Erlonat Tablets
Get Price Quote
50 Pack (MOQ)
Erlonat 150 mg Tablet belongs to the group of medicine called ‘anti-cancer’ primarily used for lung and pancreatic cancer treatment. Lung cancer is the uncontrolled growth of abnormal cells in one or both lungs. These abnormal cells do not carry out normal lung cell functions and do not develop into healthy lung tissue. In this disease, cells of the lung grow uncontrollably, and if not detected at an early stage may spread to other body parts, including the brain. Pancreatic cancer is an uncontrolled cancerous growth in the pancreas, usually in the cells that produce insulin. Erlonat 150 mg Tablet contains 'Erlotinib' that belongs to the group of medicines known as 'kinase inhibitors'. It works by stopping the action of an abnormal protein that causes the multiplication of cancerous cells. In this way, it prevents the spread of cancerous cells.
ERLOTINIB TABLET 100MG & 150 MG
Get Price Quote
Erlotinib Tablet is indicated for: The first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor(EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations as detected by an FDA-approved test. The maintenance treatment of patients with locally advanced or metastatic non-small cell lung cancer, whose disease has not progressed after four cycles of platinum-based first-line chemotherapy. The treatment of patients with locally advanced or metastatic non- small cell lung cancer after failure of at least one prior chemotherapy regimen. 3s corporation is Supplier,Exporter ,Wholesaler for Erlotinib Tablet 100mg & 150 mg in India. We even offer contract manufacturing services from WHO GMP approved factories. ADDITIONAL INFORMATION Single oral doses of Erlotinib up to 1,000 mg in healthy subjects and weekly doses up to 1,600 mg in cancer patients have been tolerated. Repeated twice-daily doses of 200 mg single-agent Erlotinib in healthy subjects were poorly tolerated after only a few days of dosing. Based on the data from these studies, an unacceptable incidence of severe adverse reactions, such as diarrhea, rash, and liver transaminase elevation, may occur above the recommended dose. SIDE EFFECTS- MOST COMMON SIDE EFFECTS Metastatic NSCLC – First-Line Treatment of Patients With EGFR Mutations: Most frequent (≥30%) adverse reactions were diarrhea, asthenia, rash, cough, dyspnea, and decreased appetite. Advanced NSCLC – Maintenance Treatment: Rash and diarrhea. Rash (9%) and diarrhea (2%). Rash and diarrhea resulted in dose reductions or interruption (5% and 3%, respectively) and discontinuation (1% and 0.5%, respectively) of Erlotinib-treated patients. Advanced NSCLC – Second/Third-Line Treatment: Rash and diarrhea. Rash (9%) and diarrhea (6%). Rash and diarrhea each resulted in dose reductions (6% and 1%, respectively) and discontinuation in 1% of Erlotinib-treated patients. Advanced Pancreatic Cancer –Erlotinib Administered Concurrently with Gemcitabine: Fatigue, rash, nausea, anorexia, and diarrhea. Grade 3/4 (NCI-CTC Version 2.0) adverse reactions were rash (5%) and diarrhea (5%). Rash and diarrhea each resulted in dose reductions in 2% of patients and discontinuation in up to 1% of patients receiving Erlotinib plus gemcitabine.
Erlocip 150 Tablets
6,910 - 7,250 Per Bottle
30 Bottle (MOQ)
Erlocip 150 mg Tablet is an anticancer medication utilized for the therapy of non-little cell cellular breakdown in the lungs. It is likewise utilized in a blend with gemcitabine to treat pancreatic malignant growth. This medication isn't suggested for use in that frame of mind than 18 years old.
Erlotinib Tablets
7,200 Per Box
Erlotinib Tablets
Get Price Quote
1 Box (MOQ)
Post Free Ad
5.0
